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Abstract
We have previously demonstrated that Stat3 regulates lysosomal mediated-programmed cell death
(LM-PCD) during mouse mammary gland involution in vivo. However, the mechanism that
controls the release of lysosomal cathepsins to initiate cell death in this context has not been
elucidated. We show here that Stat3 regulates the formation of large lysosomal vacuoles that
contain triglyceride. Furthermore, we demonstrate that milk fat globules (MFGs) are toxic to
epithelial cells and that, when applied to purified lysosomes, the MFG hydrolysate oleic acid
potently induces lysosomal leakiness. Additionally, uptake of secreted MFGs coated in
butyrophilin 1A1 is diminished in Stat3 ablated mammary glands while loss of the phagocytosis
bridging molecule MFG-E8 results in reduced leakage of cathepsins in vivo. We propose that Stat3
regulates LM-PCD in mouse mammary gland by switching cellular function from secretion to
uptake of MFGs. Thereafter, perturbation of lysosomal vesicle membranes by high levels of free
fatty acids results in controlled leakage of cathepsins culminating in cell death.
INTRODUCTION
Lysosomes are key eukaryotic organelles that are essential for the turnover of cellular
macromolecules and organelles that are delivered via the endocytic, autophagic and
phagocytic membrane trafficking pathways1. Whilst previously considered simply as the
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final destination for cargo intended for breakdown it is becoming increasingly apparent that
lysosomes, and their acid hydrolase contents, possess many other specific functions.
Notably, this includes the initiation or enhancement of cell death programmes as a result of
permeabilisation of lysosomal membranes and the subsequent leakage of cathepsins and
other constituents into the cytosol, where they can act as executioner proteases1-3. Aberrant
lysosomal function is associated with ageing and neurodegenerative disorders such as
Parkinson’s disease and lysosomal storage disorders4, 5. Furthermore, cellular
transformation is characterised by lysosomal modifications, including changes to their size,
localisation and composition and enhanced secretion of their contents to the extracellular
space, promoting tumour progression, invasion and metastasis6-8. Conversely, apoptosis or
lysosomal-mediated cell death can be induced by the intracellular release of lysosomal
hydrolases, providing a rationale for utilising anti-cancer drugs that destabilise lysosomal
membranes7, 9.
An exquisite example of controlled physiological cell death is the post-lactational regression
(involution) of the mammary gland, one of the major cell death events to occur in the adult
mammalian organism10,11. During pregnancy, alveolar epithelial progenitor cells are
stimulated to proliferate and differentiate in response to progesterone and prolactin in order
to provide mammary tissue with the secretory cells necessary for milk production during
lactation12. This includes secretion of milk proteins as well as MFGs via a unique
mechanism that requires butyrophilin 1A1 (BTN) and xanthine dehydrogenase/
oxidoreductase (XDH)13. A complex and highly regulated programme of cell death and
tissue remodelling is initiated upon cessation of lactation to remove alveolar mammary
epithelium and return the gland to its pre-pregnant state11. This process occurs in two
phases, with the first phase (0-48h in the mouse) being reversible such that re-introduction
of the pups can re-initiate lactation14. Prolactin-induced Stat5 signalling is abrogated, and
LIF-induced Stat3 signalling is initiated, upon induction of involution. Stat3 is indispensable
for this process as mice with a mammary epithelial-specific knockout of Stat3 display
diminished cell death and a severe delay in post-lactational regression of the gland15, 16.
We have shown previously that cell death in the regressing mammary gland occurs
independently of caspases, relying instead on lysosomal membrane permeabilisation (LMP)
and the release of cathepsin proteases to the cytosol17. Intriguingly, this mode of cell death
is unlikely to be restricted to the mammary gland. Cell death during hormonoprivic
involution of the prostate gland18 and in the labial gland of the tobacco hornworm, bear
striking similarities to LM-PCD in mammary epithelial cells during involution19. Stat3
regulates this process by stimulating the expression of cathepsins B and L, in addition to
concurrently suppressing expression of the endogenous cathepsin inhibitor, Spi2A17. This
latter event leaves mammary epithelial cells particularly susceptible to cell death from the
amplified activity of cathepsins that have leaked from lysosomal structures. A role for LMP
in mediating a physiological cell death program, rather than in pathological conditions or as
a back-up mechanism for refractory apoptosis had not been previously described20.
A number of mechanisms have been proposed for LMP in different cellular contexts in vitro
including lysosomotropic detergents, toxins, reactive oxygen species, and translocation of
Bax to the lysosomal membrane21-23. However, a definitive mechanism driving LMP in
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vivo, and the specific role of Stat3 in this process, has yet to be elucidated. We hypothesised
that Stat3 drives a series of biological events in the regressing mammary gland that
amplifies the lysosomal system at a time of increased demand and stress, while concurrently
exploiting this to mediate lysosomal-dependent cell death. We have explored this notion by
investigating the micro-architecture of mammary epithelial cells in lactating and involuting
mammary glands and discovered that Stat3 mediates the formation and fusion of large
lysosomal-like vacuoles many of which contain triglyceride. This is subsequently
metabolised to free fatty acids, including oleic acid, that can distort membranes and result in
leakage of cathepsins from lysosomes. We also reveal that Stat3 promotes a phenotypic
switch from secretion to phagocytosis of MFGs, the latter function delivering triglyceride to
vacuoles with the ensuing consequences of LMP and cell death.
Results
Large vacuolar structures appear during involution
Our initial approach to investigate the hypothesis that Stat3 both enhances, and exploits, the
lysosomal system to mediate cell death was to examine the lysosomal compartment during
mammary gland regression in more detail. We noted the appearance of large cathepsin D-
positive vacuoles upon initiation of involution (Fig. 1a). Significantly, similar vacuoles also
appear upon induction of involution in the uterus and prostate (Fig. 1a), and were often
larger than nuclei (> 5 μm). Importantly, such a dramatic increase in size is a factor that
could, of itself, sensitise lysosomes to become leaky24. Notably, the morphology of dead
cells in all three tissues was similar, being atypical for either classical apoptosis or necrosis
(Fig. 1b), and characterised by hypercondensed nuclei and a complete absence of membrane
blebbing18. This suggests a common mechanism of cell death during regression of hormone-
dependent tissues.
We then focussed our studies on these presumptive lysosomal vesicles in the regressing
mammary gland. Cathepsin D is co-ordinately upregulated with cathepsins B and L at
24-48h involution (Supplementary Fig. 1a, b) and 17, 25, 26, with large cathepsin D structures
also staining positively for the lysosomal membrane marker, LAMP2 (Fig. 1c). Several very
large LAMP2-positive lysosomal vacuoles were frequently seen within individual epithelial
cells in the involuting, but not the lactating, mammary gland (Fig. 1d). These structures were
much less apparent in tissue from Stat3fl/fl;BLG-Cre (Stat3 knockout) mice that are
specifically deleted for Stat3 in the luminal epithelium, compared to Stat3fl/fl control mice
(Fig. 1e). Quantification of the number of LAMP2-positive structures per nucleus showed a
9-fold decrease in the Stat3 knockout epithelium (Fig. 1f). This effect was observed only
during the first phase of involution. At 48 h and 72 h involution, Stat3 ablation had a
diminished effect on the presence of lysosomal vacuoles (Supplementary Fig. 1c), although
expression of cathepsins B and L is dramatically reduced at these timepoints in Stat3
knockout glands17. Upon further characterisation, triglyceride lipid was found to be a
significant constituent of the lysosomal system in involuting mammary gland (Fig. 1g and
Supplementary Fig. 1d). Thus, these large structures contain lysosomal proteins and
triglyceride showing that fusion of lysosomes with either unsecreted or re-absorbed MFGs
has taken place.
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Ultrastructural analysis of vacuoles and their contents
In order to analyse these structures in greater detail, we performed transmission electron
microscopy (TEM) on perfusion fixed mammary tissue from day10 lactation and 24h
involution. This revealed the presence of strikingly large, membrane-bound vesicles, many
of which were at least the size of nuclei with some occupying most of the cell (Fig. 2a).
These have been observed also by TEM at day 3 involution27. Notably, these were present
only during involution and not at day10 lactation (Fig. 2a). Once again, in agreement with
our observations on LAMP2-positive vacuoles, these large vacuoles were much less
abundant in Stat3 knockout tissue (Fig. 2a). Additionally, we noted that mitochondria
acquire an elongated morphology upon the switch from lactation to involution that occurred
regardless of Stat3 status (Fig. 2a). This has previously been described as an adaptive
response to a highly autophagic environment28. The presence of morphologically sound
mitochondria, which appeared similar in both control and Stat3 deficient mammary tissue at
24h involution, further supports our previous data showing that cell death at this time is
caspase independent17. Confirming results in Figure 1a and c, immunogold staining for
cathepsin D showed this lysosomal enzyme to be focally associated with degrading material
contained within vacuoles (Fig. 2b), revealing their lysosomal origin. Vacuoles containing
autophagic contents (Fig. 2c), milk protein (Fid. 2d, e) and triglyceride (Fig. 2 f-i) were
frequently observed to be in the process of fusion with other membrane bound structures
(Fig. 2c, e and f), clearly demonstrating an active process of vesicle biogenesis.
Furthermore, lipid was observed inside lysosomal structures that also contained electron-
dense lipofuscin-like material (Fig. 2h, i), confirming hydrolysis of bulk triglyceride from
lipid droplets in the lysosomal compartment.
Vesicles are induced by Stat3 in mammary epithelial cells in vitro
Intrigued by the association of large lysosomal vacuoles with the initiation of cell death, and
their absence in the Stat3 knockout, we sought to determine a mechanistic involvement of
these structures in the execution of cell death. To address this question, we utilised
oncostatin M (OSM) stimulation of the EpH4 mammary epithelial cell line, which we have
previously shown to mimic Stat3-induced LM-PCD17. We observed a number of vacuoles/
vesicles in unstimulated EpH4 cells presumably generated by autophagy and by pinocytosis
of the culture medium (Fig. 3a). We then determined whether activation of Stat3 by OSM
resulted in a stimulation of the biogenesis of such vesicles. This was indeed the case with
OSM treatment resulting in a 1.7-fold increase in the volume fraction of degradative vesicles
after 72 h treatment as determined by TEM (Fig. 3 b-d).
Milk-derived lipid and fatty acids are toxic to mammary epithelial cells
Having confirmed that EpH4 cells can take up substances from the culture medium we
incubated cells with freshly collected mouse milk which resulted in lipid accumulation (Fig.
4a) and induction of cell death, as measured by phase contrast microscopy (Fig. 4a) and cell
viability analysis (Fig. 4b).
Immunofluorescence imaging of milk-fed EpH4 cells revealed lipid localising to lysosomal
compartments (Supplementary Fig. 2a), while co-treating with Bafilomycin A1, a potent and
selective inhibitor of the vacuolar-type H+ ATPase 29 that inhibits lysosomal acidification
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and vesicular fusion, resulted in a partial rescue of milk-induced cytotoxicity (Fig. 4c,d),
suggesting that lysosomal lipid accumulation induces cell death.
The toxicity of milk could be due to several components as it contains protein, triglyceride,
carbohydrates, minerals and antibodies. Triglycerides are the primary constituent of
MFGs 30 that are degraded in the lysosome during involution, yielding potentially high local
concentrations of free fatty acids. Thin layer chromatography (TLC) analysis (Fig. 4e)
revealed that free fatty acids are present in the mammary gland during involution, but are
not detectable during lactation. Free fatty acid concentration as measured by TLC, using
oleic acid standards, averaged 4.8 μg/20mg tissue (Fig. 4f,g), which corresponds to a tissue
level of approximately 850 μM free fatty acid (see Methods). It should be noted that only
unsaturated free fatty acid could be detected using this system implying that 850 μM is a
conservative estimate.
The fatty acids found in milk triglycerides are summarised in Supplementary Table 1, with
oleic (CH3(CH2)7CH=CH(CH2)7CO2H) and palmitic (CH3(CH2)14CO2H) acids being the
most abundant31 and hence chosen for further analysis in vitro. Stearic acid
(CH3(CH2)16CO2H) was also used, as it has the same number of carbon atoms as oleic acid
but lacks the double bond.
The role of free fatty acids in lysosome permeabilisation and cell death was then
investigated using EpH4 cells. Treatment with physiological levels of oleic and palmitic
acids (as determined in Fig. 4e-g) resulted in lipid accumulation and toxicity, as observed by
phase contrast microscopy and cell viability analysis (Fig. 4h,i and, Supplementary Fig.
2b,c). Notably, oleic acid treatment resulted in more staining for triglyceride than palmitic
acid. Stearic acid treatment resulted in less lipid accumulation, but no cytotoxicity was
observed at equivalent concentrations to oleic and palmitic acids (Figure 4i). The ability of
oleic acid to elicit more triglyceride synthesis is well documented32 and is considered a
protective mechanism from the toxic effects of oleic acid exposure.
Cathepsin activity assays and immunoblot analysis on digitonin-extracted cytosolic fractions
(optimised for digitonin concentration to avoid damage to lysosomes; Supplementary Fig.
3a) of fatty acid treated EpH4 cells revealed that oleic acid caused a significant release of
cathepsins to the cytosol (Fig. 5a). Immunoblot analysis of these samples further
demonstrated that only oleic acid induces significant release of cathepsin L to the cytosol
(Fig. 5b). In contrast, palmitic acid treatment resulted in limited release of cathepsins to the
cytosol, which was not significant. Importantly stearic acid, the saturated carbon chain
counterpart of oleic acid, also had no effect on cathepsin release as measured by cytosolic
cathepsin activity assays and immunoblot (Fig. 5a,b). Staining with the lysosomotropic dye
LysoTracker® Red showed that both oleic and palmitic acid treatment resulted in an
appearance of a population of cells with low Lysotracker® intensities, indicative of
lysosomal de-acidification (Supplementary Fig. 3b,c). Of note, fatty acid treatment did not
appear to induce the translocation of the pore-forming protein Bax to lysosomes in EpH4
cells (Supplementary Fig. 4). Therefore, these data clearly demonstrate that lysosomal
membranes can be permeabilised efficiently by oleic acid. However, an effect of palmitic
acid cannot be completely excluded.
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Oleic acid treatment permeabilises purified lysosomes
It has been observed that palmitic, but not oleic acid, induces cell death by ROS-mediated
mitochondrial disruption33. In order to exclude potential indirect effects such as
mitochondrial ROS-induced perturbations upstream of lysosomal permeability34 we isolated
lysosomes from EpH4 cells using a magnetic nanoparticle separation protocol (Fig. 5c),
which produces pure lysosomal preparations uncontaminated by mitochondria (Fig. 5d).
Addition of fatty acids to purified lysosomes for up to 30 mins followed by immunoblot
analysis showed leakage of cathepsin L in the presence of oleic acid while lysosomes were
essentially intact in the presence of palmitic acid (Fig. 5e). Thus, oleic acid is a potent
lysosomal permeabilisation agent at concentrations below that present locally in the
mammary gland during involution, whilst palmitic acid is unable to permeabilise
membranes within the timeframe studied. Oleic acid possesses an unsaturated cis-bond and
adopts a kinked conformation which has been shown to distort synthetic membranes and
leads to their de-stabilisation upon insertion35 (Fig. 5f). In contrast, palmitic and stearic acid
are linear in conformation as they lack a double bond. Thus, the increased potency of oleic
acid is likely to be due to the kink in its structure. The oleic acid-bovine α-lactalbumin
complex, BAMLET, has been hypothesized to cause LM-PCD by interaction with the
lysosomal membrane36. However, it has since emerged that cell death caused by BAMLET,
and its human counterpart HAMLET, is due solely to the function of α-lactalbumin as a
carrier for oleic acid37. Our data support this observation and emphasise the potency of oleic
acid as a phospholipid membrane destabiliser. Since this leak of cathepsins mimics our
observations in vivo17, we suggest that insertion of MFG-derived fatty acids, and in
particular oleic acid, into the limiting membrane of these lysosomal vesicles produces
membrane distortions resulting in leakage of cathepsins into the cytosol. This posit is further
supported by the slow leak of cathepsins17 and the essentially intact lysosomal/vacuolar
membranes observed during involution in vivo (Fig. 2).
Stat3 mediates uptake of BTN-coated MFGs
In the process of being secreted, MFGs become coated with BTN, which is essential for
their secretion38. BTN can be visualised as a thin ring surrounding MFGs secreted into the
alveolar lumen at day 10 lactation (Fig. 6a). Notably, unsecreted lipid droplets within the
mammary epithelium do not stain for BTN38. At 24 h involution, the appearance of MFGs
coated with BTN becomes strikingly evident within the mammary epithelium (Fig. 6a). This
is Stat3 dependent as considerably fewer MFGs coated with BTN are evident in
Stat3fl/fl;BLG-Cre glands at 24 h involution (Fig. 6b) indicating reduced uptake of MFGs.
Interestingly, microarray analysis indicates that expression of BTN and XDH is suppressed
at the onset of involution (Fig. 6c) and 39 (www.path.cam.ac.uk/~madgroup). Quantitative
PCR analysis shows these genes are upregulated in Stat3 KO mammary gland at 24 h
involution, suggesting Stat3 represses XDH and BTN transcription (Supplementary Table
2). Immunoblot of Stat3 knockout and control mammary tissue corroborates the role of Stat3
in suppressing BTN expression (Fig. 6d).
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MFGs are taken up by mammary epithelial cells via phagocytosis
Having firmly established the presence of triglyceride lipid in secondary lysosomes, we
sought to define how lipid was trafficked to these large lysosomal vacuoles. Intracellular
lipid can be delivered to the lysosome via macroautophagy (lipophagy)40. However, having
shown that BTN-coated secreted lipid droplets were being taken up by the alveolar
epithelium, we looked for further evidence of endocytic uptake.
As demonstrated by BTN staining in Figure 6, MFGs observed in the alveolar lumen with
TEM are surrounded by a thin rim of plasma membrane-encased cytosol and the MFG
membrane (Fig. 7a). This latter structure is acquired by the lipid droplet during the secretion
process from the apical surface of the epithelium13 and is direct evidence that intracellular
lipid droplets are taken up by an endocytic pathway. Indication of macropinocytosis is seen
at the plasmalemma, where membranous ruffles capture luminal fluid (Fig. 7b). In
agreement with this, macropinosomes, some containing lipid droplets, are seen within the
epithelium (Fig. 7c). However, large MFGs that have come from the alveolar lumen are also
taken up by phagocytosis. MFGs are seen inside tightly fitting phagosomes within the
epithelium (Fig. 7d-f). The luminal origin of fat droplets (that can measure 8 μm in
diameter) is confirmed by the presence of the MFG membrane that is found in close
proximity to the limiting phagosomal membrane (Fig. 7f). The highly phagocytic nature of
involuting mammary gland epithelium is seen clearly in cathepsin L knockout mice that, in
contrast to control animals, cannot efficiently degrade cell corpses within the
phagolysosome, thereby allowing visualisation of phagocytosed material (Fig. 7g). Further
support that mammary epithelial cells become phagocytes41 comes from expression of the
recognition molecule CD14, on the luminal surface in a Stat3 dependent manner at 24 h
involution42. These data unequivocally demonstrate that mammary epithelial cells become
phagocytes during involution and thus deliver MFGs to lysosomes.
Delivery of MFGs by phagocytosis would traffic MFGs to lysosomes for hydrolysis and
generation of toxic free fatty acids43. In support of this contention, knockout of the
phagocytosis bridging molecule MFG-E8 slows mammary gland involution44, 45. MFG-E8
staining is clearly visible on MFGs and dead cells within the alveolar lumen during
involution (Fig. 7h). As expected, luminal MFG-E8 staining is abolished in MFG-E8
knockout tissue (Fig. 7h) and corresponds with decreased leakage of cathepsin proteases
from lysosomes at 24 h involution as measured by cytosolic cathepsin activity (Figure 7i).
This strongly suggests that phagocytosis of MGFs by viable epithelium results in lysosomal
damage.
Thus, we propose a model for Stat3 mediated cell death during involution, which
encompasses this switch in mammary epithelial phenotype from a secretory cell to non-
professional phagocyte (Fig. 8). To embrace this role, Stat3 powerfully enhances the
lysosomal system while at the same time suppressing expression of the protective cytosolic
protease inhibitor Spi2a. Uptake of triglyceride and delivery to lysosomes, with subsequent
production of fatty acids, results in permeabilisation of large lysosomal vacuoles. The
consequent leakage of cathepsin proteases into the cytosol is the final fatal step that causes
physiological LM-PCD in the involuting mammary gland (Fig. 8).
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Discussion
Cell death during involution of the mammary gland is a genetically controlled process that is
both dramatic in scope and efficient in execution. Although assumed to be an apoptotic
process, our previous work suggested a non-apoptotic mechanism that required both Stat3
and leakage of cathepsins from lysosomes through lysosomal membrane permeabilisation
(LMP)17. Many mechanisms of LMP in different cell types have been described in vitro,
often with conflicting results and no consensus has been reached. We have thus focused on
deciphering the mechanism of LMP in the in vivo context of mammary gland involution
where cell death is a developmentally regulated physiological process.
Upon examination of involuting mammary tissue, we noted the association of cell death
with the formation and fusion of large cytosolic vacuoles, many of which contained
triglyceride, milk protein and degraded membranes. Furthermore, the appearance of these
vacuoles requires Stat3, suggesting that this is a transcriptionally regulated event.
Importantly, we show here that involution of other tissues such as prostate and uterus is
characterised by similar histological hallmarks suggesting that formation of vacuoles and
their fusion with lysosomes, leading to leakage of their cathepsin protease contents, could be
a conserved mechanism of developmental cell death in hormone-dependent tissues.
The presence of vacuoles has previously been described in some forms of caspase-
independent cell death in a variety of organisms. One of the earliest descriptions is of cells
dying during metamorphosis of insect intersegmental muscle cells46. The role of vacuoles in
plant cell death, during the formation and elimination of tissue, is well established and is
associated with release of hydrolases from collapsed lytic vacuoles47, 48, while vacuolisation
is a prominent feature of dying Dictyostelium discoideum cells49. More recently, an
activated form of the H-Ras oncoprotein was shown to induce extensive vacuolisation by
macropinocytosis with subsequent cell death in cultured carcinoma cells. This process was
named methuosis50. Furthermore, a small molecule named Vacquinol-1 was shown to
induce catastrophic vacuolisation in glioblastoma cells51 highlighting the utility of such an
approach for killing apoptosis-resistant cancers.
Interestingly, while vacuolisation of itself can kill, delivery of triglyceride to lysosomes
accelerates this process. EpH4 mammary epithelial cells die 72 h after the induction of
extensive vacuolisation, whilst the addition of milk to these cells can induce cell death
within 24 h. In vivo, dying mammary cells are shed into the alveolar lumen within 12 h of
milk stasis and extensive cell death is apparent by 24 h involution. Thus, we suggest that the
genetic control of vacuolisation, coupled with regulated uptake of triglyceride, is a potent
inducer of cell death in mammary tissue. Furthermore, many diseases such as non-alcoholic
liver disease, obesity and diabetes are characterised by cellular uptake of lipid52. Thus, this
mechanism of cell death may be utilised more widely.
This work delineates a fundamental mechanism for LMP in vivo. The role of vacuolisation
in this process is intriguing and may signify that the late evolving mammary gland has
hijacked an ancient mechanism embraced by social amoebae and the plant kingdom for
regulated cell death. Lastly, changes to the lysosomal compartment during mammary gland
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involution are reminiscent of changes in cancer cells, many of which are refractory to
apoptosis and frequently harbour constitutively active Stat353. Thus understanding the
mechanism of LMP, and the critical role of Stat3 in this process, will provide new
approaches to cancer therapy.
Methods Summary
Animal Husbandry
C57BL/6J wild-type mice were used for lipidtox stained sections, lipid analysis by TLC and
in electron microscopy experiments. Stat3fl/fl (control) or Stat3fl/fl;BLG-Cre (Stat3
knockout) mice are on a mixed background and were generated by crossing mice carrying
loxP flanked stat354 with mice containing a β-lactoglobulin-promoter-driven Cre gene55.
Other mouse strains used were cathepsin L knockout mice56 and MFG-E8 knockout mice
expressing a β-galactosidase-containing fusion protein under the control of the endogenous
Mfge8 promoter57 (both strains on a C57L/6J background). Prostate sections were taken
from NOD scid gamma mice (males aged between 4-6 months). Uterus samples were from
129 (involuting) or MF1 (control) background strain female mice that were between 4-6
months old. The mice were bred in regular IVC cages with food and water ad libitum and
environmental enrichment. For mammary gland studies, virgin female mice between the
ages of 7-10 weeks old were mated and males subsequently removed before birth to avoid
second pregnancies. For involution studies, pups were removed at 10 days of lactation and
dams killed at indicated time points. At least three mice were used for each time point in
every experiment, with precise numbers indicated in figure legends. Animals were
randomised between the groups and within cohorts of the same genotype. No statistical
method was used to determine predetermine sample size. The investigators were blinded
where possible, including the histological counting undertaken for Figure 6b. All animal
experimentation was carried out in accordance with Animal (Scientific Procedures) Act
1986 and local ethical committee approval. Mice were sacrificed by dislocation of the neck,
or terminal anaesthesia for TEM analysis.
Cell culture
EpH4 cells58 were maintained in DMEM (Life Technologies) media supplemented with
10% FCS (Sigma) at 37 °C in a humidified atmosphere of 5% CO2. Milk collected from 24
h involuting mammary glands was incubated on cells diluted to 10% in media. 400 μl was
used in a 4 cm2 well. Fatty acids purchased from Sigma-Aldrich (stearate, S3381, palmitate,
P9767 and oleate O7501) were dissolved in ethanol and used at concentrations indicated in
figure legends. Cells were treated with milk and fatty acids for 8 h or overnight as indicated.
Cytotoxicity was assessed by trypan blue exclusion. For OSM stimulation cells were
stimulated at 50% confluency with a final concentration of 25 ng ml−1 recombinant mouse
Oncostatin M (495-MO, R&D Systems) or carrier (0.0001% BSA in PBS). Medium was
renewed every 48 h. Cells were pre-treated with 200nM Bafilomycin A1 (Sigma) for 1 h
prior to milk addition for further 8 h.
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Immunohistochemistry
For histological analysis on paraffin embedded tissues, abdominal glands were fixed in 4%
formaldehyde in PBS overnight at room temperature. Glands were transferred to 70%
ethanol and stored at −20 °C until embedding in wax and sectioned at 5 μm. Perfuse-fixed
glands were embedded in wax or OCT for cryo-sections. Paraffin-embedded sections were
de-paraffinized in xylene, and antigen retrieval performed by boiling in 10 mM Tri-sodium
citrate buffer, pH 6.0, for 10 min. Sections were blocked in 10% goat serum (Sigma) in PBS,
or normal chick serum (Sigma) in the case of Cathepsin D, for 1 h at room temperature.
Sections were incubated with primary antibody overnight at 4 °C. Primary antibodies used
were: rat anti-LAMP2 (ab13524, Abcam 1:50), rabbit anti-E-cadherin (#3195s, Cell
Signalling Technologies, 1:200), goat anti-cathepsin D (AF1029, R&D Systems, 1:200),
rabbit anti-BTN 1A1 (a generous gift from Dr Ian Mather, 1:5000) and armenian hamster
anti-MFGE8 (clone 18A2, a generous gift). Secondary antibodies used were Alexa Fluor
488 goat anti-rabbit IgG (Life Technologies; 1 : 500) Cy3 goat anti-rat IgG (Life
Technologies; 1 : 500) and Cy3 chicken anti-goat IgG (Life Technologies; 1 : 500). Lipidtox
(H34475, Life Technologies) staining in vivo was performed on perfuse-fixed,
cryosectioned tissues at 1:200. Nuclei were counterstained with Hoechst 33342 (Sigma
Aldrich; 1 : 1000).
For tissue-culture samples, EpH4 cells were seeded on glass coverslips. Cells were fixed
with 4% paraformaldehyde for 10 min, permeabilized with 0.1% saponin in PBS for 10 min
and blocked in 10% normal goat serum (Sigma) in PBS, 0.01% saponin for 1 h at room
temperature. Cells were incubated with primary antibody in 10% normal goat serum and
0.01% saponin in PBS overnight at 4 °C. Primary antibodies used were rat anti-LAMP2
(ab13524, Abcam 1:200) and rabbit anti-AIF (#4642s, Cell Signalling Technologies, 1:100).
Fluorescent secondary antibodies and nuclei visualisation was as above for tissue sections.
Cells were stained with Lipidtox (H34475, Life Technologies) and LysoTracker Red
DND-99 (Life Technologies) at 1:1000 and 1:10,000 respectively for 30 min at room
temperature. Pictures were acquired on a Zeiss Axioplan 2 microscope (Zeiss, Jena,
Germany) or on a Zeiss LSM 700 confocal microscope.
Transmission electron microscopy
Mice used for transmission electron microscopy analysis of ultrastructure were perfuse-fixed
with 3% glutaraldehyde, 1% formaldehyde. Three mice were used for each group.
Immunogold staining for cathepsin D was performed on tissue perfuse-fixed with 6%
formaldehyde. Anti-cathepsin D was used at 1:200. The secondary rabbit anti-goat IgG
10nm gold (#RAG10, BBI Solutions) was used at a dilution of 1:200.
Thin layer chromatography
Thin layer chromatography (TLC) was performed using standard conditions. Briefly, tissue
frozen in liquid nitrogen was powdered and extracted in two changes of chloroform
methanol (2:1). Samples were spotted on a TLC plates (1.16487.0001, Merck) and resolved
in hexane:diethyl ether:formic acid (74:25:1). The plate was charred at 100 °C after being
sprayed with 10% sulfuric acid. Bands corresponding to free fatty acids, as determined by an
oleic acid standard (Sigma), were quantified by using area under the curve analysis in
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ImageJ software. Amounts of free fatty acid were converted to tissue concentration using the
following calculations:
Average micrograms of free fatty acid on TLC plate = 4.79 μg
20 mg of tissue was loaded on each lane of the TLC plate
Therefore, there was 4.79/20 or 0.24 μg per mg of tissue (0.24 μg/mg)
As 1 mg of tissue approximates to 1 μl of volume, 0.24 μg/mg = 0.24 μg/ul
0.24 μg/μl × 106 = 240,000 μg/l or 0.24 g/l
Oleic acid Mw = 282 g/mol
0.24 g/l / 282 g/mol = 851 μM
Subcellular fractionation of mammary gland tissue
Lymph node dissected number four glands were minced using scalpel blades on ice prior to
homogenisation in a tight-fitting handheld homogenizer (12 stokes) in 1 ml of subcellular
fractionation buffer (HEPES-KOH 20 mM, sucrose 250 mM, KCl 10 mM, MgCl2 1.5 mM,
EDTA 1 mM, EGTA 1 mM, dithiothreitol 8 mM, Pefabloc 1 mM (Fluka), at pH 7.5). Debris
and nuclei were pelleted in a tabletop centrifuge (Heraeus Fresco-17 centrifuge) at 750 g
(3,500 r.p.m.) for 10 min, 4 °C. The supernatant was spun at 10,000 g (12,900 r.p.m.) for 15
min at 4 °C, to pellet organelles. The supernatant, containing cytosolic and extracellular
components was spun at 100,000 g (40,000 r.p.m.) for 1 h at 4 °C in a BeckmanCoulter
Optima L-100 XP Ultracentrifuge to remove microsomes and collected as cytosolic fraction.
Digitonin extraction of EpH4 cells
Cytosolic extraction using digitonin was performed as previously described59 with the
exception that digitonin was used at 25 μg/ml. Briefly, cells were seeded in six-well
Nunclon Δ Surface plates (Nunc, 150,000 cells per well) in DMEM, 10% FCS (Gibco/
Sigma) and next day treated with free fatty acids as indicated. Cells were harvested and
counted, with 175,000 cells pelleted and extracted with 300 μl of 25 μg/ml Digitonin
(300410, Calbiochem) in subcellular fractionation buffer (HEPES-KOH 20mM, sucrose 250
mM, KCl 10 mM, MgCl2 1.5 mM, EDTA 1 mM, EGTA 1 mM, dithiothreitol 8 mM,
Pefabloc 1 mM (Fluka), at pH 7.5), a concentration that had been determined to be optimal
(concentrations ranging from 12.5-50 μg/ml were tested and 25 μg/ml showed good
cytosolic extraction, with minimal lysosomal damage). Cells were incubated for 10 min on
ice with intermittent vortexing. The samples were then spun down (90 s, 13,000 r.p.m., 4
°C) and the supernatant quickly transferred to a new tube to be used in downstream
cathepsin activity assays. For each condition 175,000 cells were also extracted in 0.1%
TritonX-100 as above to obtain total cell lysates for assessing total cathepsin activity.
Sargeant et al. Page 11
Nat Cell Biol. Author manuscript.
 Europe PM
C
 Funders A
uthor M
anuscripts
 Europe PM
C
 Funders A
uthor M
anuscripts
Cathepsin activity assay
To measure cytosolic cathepsin activity subcellular fractionation was carried out on
mammary glands as described above. Protein levels were assessed with the BCA Protein
Assay (Thermo Fisher Scientific, Waltham, MA, USA) and equal amounts of protein (4 μg)
were added to a total of 200 μl cathepsin reaction buffer (sodium acetate 50 mM, EDTA 8
mM, dithiothreitol 8 mM and Pefabloc subcellular fractionation buffer 1 mM, at pH 6).
Cathepsin B+L activity was measured after incubation (30 min, 37 °C) with the fluorescent
substrate Z- Phe-Arg-AMC (50 μM; Merk Millipore, Darmstadt, Germany) in a Synergy HT
Multi-Detection Microplate Reader (excitation 380 nM, emission 442 nM; Bio-TEK,
Winooski, VT, USA). For assessment of cytosolic cathepsin activity in EpH4 cells treated
with free fatty acids 10 μl of digitonin extracted lysates was added to a total of 200 μl
cathepsin reaction buffer (sodium acetate 50 mM, EDTA 8 mM, dithiothreitol 8 mM and
Pefabloc subcellular fractionation buffer 1 mM, at pH 6) and the fluorescent cathepsin
substrate Z- Phe-Arg-AMC (50 μM as above) and fluorescence measured immediately every
minute for 1 h at 37 °C (excitation 380 nM, emission 442 nM as above). Initial rates of
cathepsin B and L activity were determined from the linear part of the resulting curve and
normalised to total cathepsin activity obtained from TritonX-100 extracted lysates.
Lysosomal purification and leakiness assay
Lysosomes from EpH4 cells were purified using magnetic iron nanoparticles (EMG-508,
Ferrotec) as previously described60. Briefly, EpH4 cells were seeded at a density of 3×106 in
15 cm tissue culture plates (168381, Nunc). The following day cells were labelled for 4 h in
iron nanoparticle containing media (1:100) followed by a 20 h chase period in clean media.
Cells were then scraped off in PBS, pelleted in a tabletop centrifuge (300 r.p.m., 4 °C, 3
min) and the pellet homogenised in a tight-fitting handheld homogenizer (5 stokes) in 700 μl
subcellular fractionation buffer (HEPES-KOH 20 mM, sucrose 250 mM, KCl 10 mM,
MgCl2 1.5 mM, EDTA 1 mM, EGTA 1 mM, dithiothreitol 8 mM, Complete protease
inhibitor (Roche) at pH 7.5). The homogenate was spun at 750 g (3,500 r.p.m., 4°C, 10 min)
to remove nuclei and debri, followed by a second 750 g spin to ensure complete removal of
contaminating heavy membranes. The resulting supernatant (pns; post nuclear supernatant)
is transferred into a clean tube, loaded onto a magnetic rack and incubated for 1 h at 4 °C on
a rocker. A 50 μl sample of pns is retained for analysis. Following incubation tubes are left
on the magnet as the supernatant (sn) is removed (retaining 50 μl for analysis). Tubes are
washed with 1 ml of subcellular fraction buffer three times. Following addition of last wash
tubes are removed and spun at 12,000 r.p.m. (13,800 g, 4 °C, 15 min) to pellet magnetite-
containing lysosomes. Pellets were recombined in subcellular fractionation buffer and equal
amounts (30μl) aliquoted into individual tubes. Fatty acids (or ethanol control) were added
as indicated to a final concentration of 70 μM in a final volume of 60 μl. 70 μM was the
lowest concentration of oleic acid that induced reproducible cathepsin leakage. Samples
were either re-pelleted immediately (t = 0) at 12,000 r.p.m. (13,800 g, 4 °C, 15 min) or
incubated for 30 min (t = 30) at 37°C under gentle agitation. Subsequently, the lysosomes
were re-pelleted as above. The supernatant was removed and snap frozen. The pellet was
resuspended in 60 μl RIPA buffer (50 mM Tris, 1% NP40, 0.25% sodium deoxycholate, 150
mM NaCl, 1 mM EGTA and complete protease inhibitor), and organelles were lysed on ice
for 30 min with intermittent vortexing. Membranes were pelleted at 12,000 r.p.m. (13,800 g,
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4 °C, 15 min), the supernatant was removed and equal amounts of the resuspended pellet
and the supernatant were analysed by western blot. pns and sn samples were pelleted at
12,000 r.p.m. (13,800 g, 4 °C, 15 min) with the pellet resuspended in 60 μl RIPA buffer and
processed similarly to above.
Immunoblotting
Lymph node dissected mammary tissue was snap frozen in liquid nitrogen and ground to a
fine powder using a mortar and pestle. Protein from mammary gland powder was extracted
in RIPA buffer (50 mM Tris pH 7.4, 1% NP-40, 0.25% sodium deoxycholate, 150 mM
NaCl, 1 mM EGTA and 1x Complete protease inhibitor (Roche), 1 mM Na3VO4, and 1 mM
NaF). Protein concentration was assessed with the BCA Protein Assay (Thermo Fisher
Scientific, Waltham, MA, USA) and equal amounts of protein (20 μg) were denatured and
resolved on SDS-polyacrylamide gels. Immunoblotting was performed using standard
techniques and antibody detection was achieved with enhanced chemiluminescence reagent
(ECL, GE Healthcare). The following primary antibodies were used: rat anti-LAMP2
(ab13524, Abcam, 1:1000), goat anti-cathepsin L (AF1515, R&D Systems, 1:1000), mouse
anti-COX IV (ab33985, Abcam, 1:1000), goat anti-cathepsin D (AF1029, R&D Systems,
1:1000) and rabbit anti-BTN 1A1 (a generous gift from Dr Ian Mather, 1:5000).
Lysotracker Red staining and flow cytometry
EpH4 cells were seeded on six-well Nunclon Δ Surface plates (Nunc, 150,000 cells per well)
in DMEM, 10% FCS (Gibco/Sigma). Cells were treated with the indicated concentration of
free fatty acids overnight and subsequently harvested and resuspended in 500 μl culture
medium. LysoTracker Red DND-99 (Life Technologies, 100 nM) was added to the
suspension and incubated at 37 °C in the dark for 30 min. Single-colour flow cytometry was
carried out on a CyAn ADP flow cytometer (DakoCytomation), and the data were analysed
using the Summit 4.3 software (DakoCytomation).
Quantitative real-time PCR
Lymph node dissected mammary tissue was snap frozen in liquid nitrogen and ground to a
fine powder using a mortar and pestle. RNA was extracted from tissue using TRIzol (Life
Technologies) according to manufacturer’s guidelines. RNA was quantified using a
NanoDrop ND-1000 (NanoDrop Technologies) and cDNA synthesised from up to 2 μg of
RNA using the SuperScript III First-Strand Synthesis System (Life Technologies) and
random hexamers (Life Technologies). SYBR Green JumpStart TaqReadyMix (Sigma) was
used for qRT-PCR, with reactions run in a CFX Connect Real Time PCR detection System
(BioRad).
Delta Ct values were calculated by subtracting Ct values for Cyclophilin A and relative
expression derived using the delta delta Ct method. Primers used were: cyclophilin
A(housekeeping gene) forward, 5′-CCTTGGGCCGCGTCTCCTT-3′, reverse, 5′-
CACCCTGGCACATGAATCCTG-3′; Btn1a1 forward, 5′-
GCCAGGGGAAGGAAGTAGAG-3′, reverse, 5′-ATGGACCCAATGGTGAGAAA-3′;
Xdh forward, 5′-TGCAGACCCTGAAACAACAC-3′, reverse, 5′-
AAGGCGGTCATACTTGGAGA-3′
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Data analysis and Statistics
Experimental repeats have been detailed in the figure legends and in Supplementary Table 3.
For electron microscopy on animal tissue samples, vesicular fusion events were rare,
consistent with their transient nature. In all experiments there were no exclusion criteria, and
no data were excluded. All normality and statistical tests were undertaken using GraphPad
Prism v4.0a.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Enlargement of the lysosomal compartment and digestion of triglyceride in the regressing
mammary gland. (a) Large secondary lysosomes are shown by cathepsin D staining (red,
arrowheads) in different involuting tissues. Mouse uterus at 24 h post-partum and during late
pregnancy, prostate gland at 7 d post castration and uncastrated and mammary gland at 24 h
involution and 10 d lactation. Tissue was stained for cathepsin D (red) and E-cadherin
(green). (b) Hoescht staining showing dead cells (arrowheads) in the involuting mouse
uterus, prostate and mammary gland. Three independent biological repeats per condition for
prostate and mammary glands, one biological repeat per condition for uterus. (c) Dual
staining for LAMP2 and cathepsin D shows cathepsin D (red) localising to the inside of a
LAMP2-positive (green) vacuole. Three independent biological repeats were assessed. (d)
LAMP2 (red) and E-cadherin (green) staining in 10 d lactating and 24 h involuting
mammary glands. Six independent biological repeats per condition analysed. (e) LAMP2-
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positive vacuoles (red) are found in the control but not the Stat3 KO mammary gland at 24 h
involution. (f) Staining for LAMP2 at 24 h involution in control and Stat3 knockout animals
was quantified. Bars represent means +/− s.e.m. of n = 3 mice per genotype with 12-13
fields counted per mouse (*p<0.05; Student’s t-test). Statistics source data can be found in
the associated worksheet in Supplementary Table 3 (g) Confocal images showing that
cathepsin D-positive vacuoles (arrowhead) contain lipid droplets (lipidtox staining, green) in
the 24 h involuting mammary gland. Three independent biological repeats per condition
analysed. Nuclei are visualised by Hoescht stain (blue). Scale bars: (a), (d), (e) and (g) = 20
μm, (b) and (c) = 10 μm.
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Figure 2.
Ultrastructural analysis of lysosomal vacuoles and cargo delivery. (a) Transmission electron
microscopy of wild type 10 d lactation, 24 h involution and Stat3 knockout glands at 24 h
involution. (b) Immunogold staining for cathepsin D within large vacuoles at 24 h involution
co-localising with degrading material (arrowheads). (c) Autophagic vesicles fusing with
large vacuoles (arrowheads), (d) large macropinosomes full of milk inside epithelial cells
and milk containing vesicles (e) are seen to fuse with larger vacuoles. (f-i) Membrane bound
lipid fuses with vacuoles and can be observed inside lysosomal structures (arrowheads) that
contain lipofuscin-like material (arrows). Three animals assessed for all conditions except
for cathepsin D-immuno gold staining, where one animal was analysed. Scale bars: (a)
epithelial cells = 2 μm, (a) mitochondria, (b) and (c) high magnification = 500 nm, (c) low
magnification, (d-i) = 1 μm.
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Figure 3.
Vesicular biogenesis in EpH4 cells. (a) Vehicle treated Eph4 cells contain phagosomes/
pinosomes (arrowheads) and lysosomes (arrows). (b) EpH4 cells treated with oncostatin M
(OSM, 25 ng/ml) for 72 h have 53% more degradative vesicles, as quantified in panel (c) n =
4 individual wells of EpH4 cells seeded on one occasion. Phagolysosomes are marked by an
asterisk. (d) In some cases, as a result of oncostatin M treatment, lysosomal vesicles
occupied more than half of the cytosolic volume. Scale bars = 1 μm. Statistics source data
for Figure 3c can be found in the corresponding worksheet in Supplementary Table 3.
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Figure 4.
Free fatty acids are increased during involution and can cause death in vitro. (a)
Fluorescence and brightfield microscopy shows milk derived lipid accumulation (lipidtox,
green) and cell death of EpH4 cells incubated in milk overnight. Scale bars: Lipidtox
staining panels =10 μm, phase images = 100 μm. Nuclei are visualised by Hoechst (blue).
(b) Milk induced cell death assessed by trypan blue positivity. Means +/− s.e.m. from n=5
independent experiments with 3 technical replicates performed per experiment (*p<0.05;
Mann Whitney U test). (c) Bafilomycin A1 treatment partially rescues milk induced cell
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death as assessed by brightfield microscopy and trypan blue positivity. (d) Milk induced cell
death assessed by trypan blue positivity. Means +/− s.e.m. from n = 4 independent
experiments with 3-4 technical replicates performed per experiment (**p<0.01; Kruskal-
Wallis test, Dunn’s multiple comparison post-test). Scale bars: 250 μm. Cells were pre-
treated with Bafilomycin A1 for 1 h prior to milk addition for further 8 h. (e) Thin layer
chromatography was used to demonstrate the presence of free fatty acids in mammary gland
extracts. Free fatty acids were seen in force involuted mammary gland extracts but not in
lactating mammary glands (arrowhead). TG = triglyceride, PA = palmitic acid. (f) A
concentration curve of oleic acid is quantified using densitometry. (g) Quantification of the
free fatty acid band showed a significant difference between lactating and involuting
mammary gland (p<0.05, Student’s t-test, n = 4 animals). (h) Fluorescence and brightfield
microscopy showing lipid accumulation (lipidtox, green) and cell death of EpH4 cells
treated with 500 μM oleic acid (OA), palmitic acid (PA) and stearic acid (SA) overnight.
Scale bars: Lipidtox staining panels bars =10 μm, phase images = 100 μm. (i) Fatty acid
induced cell death assessed by trypan blue positivity. Means +/− s.e.m. from n = 4
independent experiments with 2-3 technical replicates performed per experiment (**p<0.01
vs ETOH control; one-way ANOVA, Dunnett’s Multiple Comparison post-test). Statistics
source data can be found in the corresponding worksheets in Supplementary Table 3.
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Figure 5.
Free fatty acids induce LMP in vitro. (a) Cathepsin activity assay on EpH4 cytosolic extracts
treated with 500 μM fatty acids for 16 h demonstrating release of cathepsins to the cytosol
by OA. Means +/−s.e.m of n = 4 independent experiments (*p<0.05; Kruskal-Wallis test,
Dunn’s multiple comparison post-test). (b) Representative sample from (a) was analysed by
western blot for Cathepsin L in total and cytosolic EpH4 extracts, showing release of
cathepsin L to the cytosol with 500 μM OA. M denotes marker lane. (c) Schematic of iron
nanoparticle lysosomal purification protocol. (d) Optimisation of iron nanoparticle mediated
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purification of lysosomes from EpH4 cells. Cells were labelled and chased as indicated
followed by extraction and immunoblotting. LAMP2, COXIV, RAB5 and RAB7 are shown
as markers for lysosomes, mitochondria, early endosomes and late endosomes respectively.
Time-course optimisation performed on one occasion. pns; post nuclear supernatant, sn; post
magnetic supernatant, mp; magnetic pellet. (e) Cathepsin L immunoblot showing extent of
leakiness from the lysosomal pellet (P) into the supernatant (S) at 30 min with 70 μM OA or
PA. Representative blot from three independent experiments. LAMP2 was used as a
lysosomal marker and COXIV used to show undetectable mitochondrial contamination. (f)
Structures of free fatty acids used in this study. Chemical structures for palmitic acid, stearic
acid and oleic acid are depicted. Statistics source data can be found in the corresponding
worksheet in Supplementary Table 3. Uncropped images of blots appear in supplementary
figure 5.
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Figure 6.
MFGs are endocytosed by mammary epithelial cells. (a) Staining for MFG membrane
protein BTN (red) in 10 d lactating and 24 h involuting mammary gland. (b) Number of
butyrophilin-positive structures per nuclei quantified in control and Stat3 knockout 24 h
involuting mammary glands. Bars represent means +/− s.e.m. of n = 3 mice per genotype,
with 34 alveoli counted per animal (*p<0.05; Student’s t-test). Statistics source data can be
found in the associated worksheet in Supplementary Table 3. E-cadherin staining is green.
Images are representative of three independent biological repeats. (c) Microarray analysis of
twelve different timepoints during the mammary gland cycle showing expression of BTN
and XDH – “Mammary Gland Pregnancy Cycle Data (.xls)” (http://www.path.cam.ac.uk/
~madgroup/microarraysummary.shtml). (d) Western blot for BTN (70 kDa) showing BTN
downregulation at 24 h involution in control but not in Stat3 knockout samples. Asterisk
indicates a spurious band. Lanes show samples from independent biological repeats. Scale
bars: (a) low magnification and (b) = 20 μm, (a) high magnification = 10 μm. Uncropped
images of blots appear in supplementary figure 5.
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Figure 7.
Uptake of MFGs occurs via macropinocytosis and phagocytosis. (a) MFGs are seen in the
alveolar lumen (arrowheads). The cytosolic ring bound by milk fat globule membrane is
inherited by the fat droplet as it is secreted through the apical plasmalemma (arrows). (b)
Ruffles on the apical plasma membrane are indicative of macropinocytosis (arrowheads). (c)
Lipid droplets (arrowhead) are present within milk laden macropinosomes in alveolar
epithelium. (d) Phagocytosed milk fat droplets can be identified within epithelium by the
presence of MFG associated cytosol and milk fat globule membrane (arrowheads). (e)
Another example of a large phagocytosed MFG is shown by arrowheads. The boxed area is
enlarged (f) to show the phagosomal membrane (arrowheads) in close apposition to the milk
fat globule membrane (arrows). (g) The highly phagocytic nature of alveolar epithelium was
demonstrated using cathepsin L KO (Ctsl KO) mice that were force involuted for 72 h. In
comparison to wild type controls, cathepsin L KO mammary glands showed accumulation of
dead cells within phagosomes (arrowhead). This phagosome is fusing with other vacuoles
(arrow). n = nucleus. (h) Staining for the phagocytosis-bridging molecule MFG-E8 (red) and
E-cadherin (green) in MFG-E8 heterozygous (control) and knockout mice. Images are
representative of three independent biological repeats. (i) Cytosolic cathepsin activity in
MFG-E8 control and knockout mice at 24 h involution. Box and whisker plot of n = 12 and
n=11 cytoplasmic fractions (mice) for control and knockout groups respectively, with 2
technical replicates performed per fraction (p=0.0173, Student’s t-test). Statistics source data
can be found in the associated worksheet in Supplementary Table 3. Scale bars: (a)-(d) = 1
μm, (e) = 4 μm and (g) = 2 μm, (f) = 500 nm, (h) = 20 μm.
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Figure 8.
A schematic model illustrating the role of Stat3 in regulating the transition from a secretory
to a phagocytic cell phenotype at the onset of involution. Subsequent cell death ensues due
to LMP caused by increase in lysosomal size and generation of free fatty acids from
hydrolysis of phagocytosed MFGs within lysosomal vacuoles and leakage of cathepsins into
a Spi2a cathepsin inhibitor depleted cytosol.
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